Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on July 7, 2025

CORRECTION – Dr. Anosh Ahmed Supports Trump’s Statement on Chicago, Citing Ongoing Public Safety and Policy Challenges
Image by Dr. Anosh Ahmed CHICAGO, July 07, 2025 (GLOBE NEWSWIRE) -- In a release issued under the same headline on June 26, 2025 9:00 ET by Dr. Anosh Ahmed, Physician and Entrepreneur, please note that the media contact should be Sandra Gomez, +1 (346) 678 …

Lifestyle Expert Meaghan Murphy Shares Her Favorite Wellness Tech for Summer Recovery with YourUpdateTV
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- With wellness and recovery more top of mind than ever, lifestyle expert and author Meaghan Murphy has teamed up with RENPHO and D S Simon Media for a special Prime Day segment featuring tech-forward self-care …

The American Society of Pain and Neuroscience (ASPN) Publishes Consensus Guidelines for the Use of 60-Day Peripheral Nerve Stimulation (PNS) Therapy, Highlighting Strong Clinical Applications for SPR® SPRINT® PNS
CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice recommendations. It includes positive recommendations for …

Joybird’s Treehouse to Host Free Webinar on Academic Success for Underserved Students
Dallas, TX , July 07, 2025 (GLOBE NEWSWIRE) -- Joybird’s Treehouse, a culturally responsive education platform founded by veteran educator Joyce Caraway, today announced its second national webinar, “Master the Grade: Keys to Academic Success …

Corza Medical Announces the Launch of the Expanded Onatec Ophthalmic Suture Portfolio
PARSIPPANY, New Jersey, July 07, 2025 (GLOBE NEWSWIRE) -- Corza Medical, a leading global medical technology company, today announced the launch of its expanded Onatec Ophthalmic Suture Portfolio. This marks a significant extension of the product range, …

Skin Care and Laser Physicians of Beverly Hills Welcomes Double Board-Certified Dermatologist
LOS ANGELES, July 07, 2025 (GLOBE NEWSWIRE) -- Skin Care and Laser Physicians of Beverly Hills are proud to introduce the newest addition to their esteemed dermatology practice in Los Angeles. Dr. Cory Kosche, a Mohs and Cosmetic Fellowship-Trained …

Nudj Health Appoints Dr. Padmaja Patel as Chief Medical Officer to Advance Lifestyle Medicine Services
PASADENA, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Nudj Health, the leading AI-powered lifestyle medicine services company, is proud to announce the appointment of Dr. Padmaja Patel as Chief Medical Officer of Lifestyle Medicine Services. In this role, Dr …

Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
MENLO PARK, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supported by a strong syndicate of early-stage …

SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, …

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting 7.5 and 66+ months, respectively Preclinical data …

Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment
THE WOODLANDS, TX, July 07, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced the next CEO Corner segment has …

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
Includes Conduit’s first composition of matter patent filing for AZD5658 and multiple new combination filings for AZD1656 and AZD5658 Patents derived from AI-led analysis conducted in partnership with Sarborg Limited NAPLES, Fla. and CAMBRIDGE, United …

Medical Supplierz Expands Global Access to Leading Medical Manufacturers
KUWAIT, KUWAIT, July 7, 2025 /EINPresswire.com/ -- Medical Supplierz, a digital B2B procurement platform, has launched new initiatives to strengthen global connectivity between verified healthcare buyers and trusted medical manufacturers. The platform …

Inspire Medical Systems, Inc. to Report Second Quarter 2025 Financial Results on August 4, 2025
MINNEAPOLIS, July 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2025 after the close of trading on Monday, August 4. Inspire’s management team will host a …

Collegium Announces $150 Million Share Repurchase Program
STOUGHTON, Mass., July 07, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced its Board …

JenaValve's Trilogy™ THV System Procedures Live Broadcast at New York Valves 2025
IRVINE, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced highlights from the New York Valves 2025 conference, with two live case …

Novel Digital Test Provides Revolutionary Tool to Assess Brain Chemistry
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals the progression of cognitive impairment and Alzheimer’s …

LENZ Therapeutics and Laboratoires Théa Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
SAN DIEGO and CLERMONT-FERRAND, France, July 07, 2025 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ) and Laboratoires Théa (“Théa”) announced an exclusive license and commercialization agreement for Théa to register and commercialize LNZ100 for …

Catheter Precision, Inc. Announces First Purchase Order From University Hospital in Rennes, France
FORT MILL, S.C., July 07, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced today that it …

UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that it has completed …